The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Broad, thanks and apologies for my misunderstanding, cheers
Broad, thanks and apologies for my misunderstanding, cheers
broad, I think 'recommending' in the sense of flagging as 'buy' etc. is really akin to advice, which I won't do.
Dont get your drift, recommended for effort not for advice.
broad, I think 'recommending' in the sense of flagging as 'buy' etc. is really akin to advice, which I won't do. Investing in AIM is inherently risky and so I think everyone should DYOR and determine their own level of acceptable the risk. I simply try to pull together info from published material from PXOG, partners and related parties. Have been a holder since Dec 2017, have only increased since then and not (as yet) sold any shares. Will be hanging on for some real return. Good luck.
LLP recommend
Peterhouse July 2018 – 2.2p fully diluted (on 1213.6m shares plus 95.6m options), valuation includes 10% CoS and 50% commercial risk for Tesorillo. What’s changed?
More shares issued, now 2213.6m (plus options). Also £480k Loan Notes (with warrants). OK, dilution and debt, but used to keep the company running and improve / increase assets.
Various delays – Italy, Spain. Bainet-West ‘duster’. On the plus side ...
Romania – some revenue.
Italy – reserves confirmed, plus upgraded Contingent Resources (2C) and Prospective Resources (2U), one more approval pending, some funding, and then production / revenue. Should see a step up if all goes to plan.
El Romeral – we have a gas producing and electricity generating asset. Drilling to follow for increased capacity utilisation and revenue.
Tesorillo – lots of work (should have been!) done with historical data re-processing and G&G integration, just waiting for CPR update and well decisions. Note that original struggling partner PRL are gone and replaced by WGO (who have a 50% share of a 1.2TCF 2C resource in Western Australia and some cash) and seem very interested in Spain – so may be driving the timeline. Depending on CPR, potential for significant re-rate.
What else – recent director buys, warrants / options due Oct / Nov this year @ 0.6p / 0.52p respectively should motivate? PXOG presentation says “huge potential NPV uplift (>€0.4B)”, if this really means ~£333m then that would be ~15p if fully realised in sp! Wonder what the Tesorillo CPR assumptions are in this?
Really need an update to the Peterhouse presentation pulling all the facts and updates together. As things stand value would seem to lie somewhere between the current ~0.14p and ~15p. Not far to go then, haha!
Above from my research (so big health warning!), i.e. please DYOR and GLA